The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rinatabart sesutecan (Rina-S) for patients with advanced endometrial cancer: First disclosure from dose expansion cohort B2 of the GTC1184-01 study.
 
Ira Winer
Consulting or Advisory Role - GOG Partners
Research Funding - Oncoceutics (Inst)
Travel, Accommodations, Expenses - Regeneron
 
Noelle Cloven
Consulting or Advisory Role - Abbvie; Genmab; GlaxoSmithKline; Toray Industries
 
Debra Richardson
Honoraria - Zentalis
Consulting or Advisory Role - Abbvie; AstraZeneca; Daiichi Sankyo/UCB Japan; Eisai; Genmab; GlaxoSmithKline; Immunogen; Incyclix Bio; Mersana; ProfoundBio; Repare Therapeutics
Research Funding - A2A Pharmaceuticals (Inst); aadi (Inst); Acrivon Therapeutics (Inst); Allorian (Inst); Aravive (Inst); Arch Oncology (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); CanariaBio (Inst); Celsion (Inst); Clovis Oncology (Inst); DualityBio (Inst); GlaxoSmithKline (Inst); Hookipa Biotech (Inst); Immunogen/Abbvie (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Mersana (Inst); Nimbus Therapeutics (Inst); Nurix (Inst); OnCusp Therapeutics (Inst); Plexxikon (Inst); PMV Pharma (Inst); ProfoundBio (Inst); Scorpion Therapeutics (Inst); Shattuck Labs (Inst); Tubulis GmbH (Inst); Valerion Therapeutics, LLC (Inst)
Travel, Accommodations, Expenses - Genmab; Society of Gynecologic Oncology
 
Lyndsay Willmott
No Relationships to Disclose
 
Justin Call
No Relationships to Disclose
 
Jessica Thomes Pepin
No Relationships to Disclose
 
Gottfried Konecny
Consulting or Advisory Role - GOG Partners
Speakers' Bureau - AstraZeneca; GlaxoSmithKline; Immunogen; Merck
Research Funding - Lilly (Inst); Merck (Inst)
Expert Testimony - Foundation Medicine
Travel, Accommodations, Expenses - TORL
 
Andrea Jewell
No Relationships to Disclose
 
Cara Mathews
Research Funding - AADI (Inst); Artios (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); avenge bio (Inst); Deciphera (Inst); Elucida Oncology (Inst); EMD Serono (Inst); Genmab (Inst); Immunogen (Inst); Laekna Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Repare Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst); Tesaro/GSK (Inst); Volastra Therapeutics (Inst); Zentalis (Inst)
 
Leigh Seamon
No Relationships to Disclose
 
Joseph Buscema
Employment - Arizona Oncology
Leadership - Arizona Oncology
Stock and Other Ownership Interests - McKesson
Honoraria - Caris Life Sciences
Consulting or Advisory Role - Caris Life Sciences; GlaxoSmithKline
 
Nurgul Kilavuz
Employment - Genmab AS
Stock and Other Ownership Interests - Genmab AS
 
Michael Gillespie
Employment - Genmab AS
Stock and Other Ownership Interests - Genmab AS
 
Ibrahima Soumaoro
Employment - Genmab
Stock and Other Ownership Interests - Bristol-Myers Squibb; Genmab
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genmab
 
Elizabeth Lee
Honoraria - AADi
Consulting or Advisory Role - AADi; Genmab; OnCusp Therapeutics
Research Funding - AADi (Inst); Genmab (Inst); KSQ Therapeutics (Inst); Merck (Inst); OnCusp Therapeutics (Inst); ProfoundBio (Inst); Repare Therapeutics (Inst); Seagen (Inst)